Search results for abx831467

Etigilimab, Abbexa, abx831467

Etigilimab is a monoclonal antibody biosimilar expressed in CHO cells, targeting TIGIT/VSTM3, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Etigilimab is a human-derived monoclonal antibody. Etigilimab targets TIGIT. It started clinical research for the treatment of advanced solid tumors in the United States in 2017 and is currently in clinical phase I.